Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
Open Access
- 1 January 2013
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 21 (1), 251-259
- https://doi.org/10.1038/mt.2012.202
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Vaccination with Messenger RNA (mRNA)Published by Springer Science and Business Media LLC ,2008
- The perfect mix: recent progress in adjuvant researchNature Reviews Microbiology, 2007
- Therapeutic anti‐tumor immunity triggered by injections of immunostimulating single‐stranded RNAEuropean Journal of Immunology, 2006
- Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-PrimingThe Journal of Immunology, 2006
- Cutting Edge: The Direct Action of Type I IFN on CD4 T Cells Is Critical for Sustaining Clonal Expansion in Response to a Viral but Not a Bacterial InfectionThe Journal of Immunology, 2006
- Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteinsBlood, 2006
- Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNAImmunity, 2005
- Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infectionThe Journal of Experimental Medicine, 2005
- Characterization of a messenger RNA polynucleotide vaccine vector.1995
- Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.The Journal of Experimental Medicine, 1993